Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-05

FDA Approved: TRETINOIN — Supplemental Application (Obagi Cosmeceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for tretinoin submitted by Obagi Cosmeceuticals LLC, indicating a modification or expansion of the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRETINOIN (TRETINOIN)

Snippet

SUPPL AP for TRETINOIN (TRETINOIN)